Inici › Sobrepès › Texas › Pharr
Assaigs clínics de Sobrepès a Pharr, TX
10 estudis de Sobrepès busquen participants en centres de Pharr i voltants (en un radi d'uns 30 milles). Obre un estudi per veure qui hi pot participar i com contactar amb l'equip.
Text oficial de l'estudi (anglès)
A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
ReclutantFase 3
- Texas Valley Clinical Research, Weslaco · a 12 mi
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
ReclutantFase 3
- Texas Valley Clinical Research, Weslaco · a 12 mi
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
ReclutantFase 3
- Texas Valley Clinical Research, Weslaco · a 12 mi
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
ReclutantFase 2
- Texas Valley Clinical Research, Weslaco · a 12 mi
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
ReclutantFase 3
- AURORA-1 Clinical Site, Weslaco · a 12 mi
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
ReclutantFase 3
- AURORA-2 Clinical Site, Weslaco · a 12 mi
A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
ReclutantFase 2
- Texas Valley Clinical Research, Weslaco · a 12 mi
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
ReclutantFase 2
- Texas Valley Clinical Research, Weslaco · a 12 mi
A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes
ReclutantFase 2
- Texas Valley Clinical Research, Weslaco · a 12 mi
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
ReclutantFase 3
- Great Lakes Research Institute - McAllen Research, Pharr
Assaigs de Sobrepès en altres ciutats
- San Antonio, TX34 estudis
- Houston, TX33 estudis
- Chicago, IL28 estudis
- Orlando, FL27 estudis
- Las Vegas, NV23 estudis
- Miami, FL23 estudis
- Atlanta, GA20 estudis
- Dallas, TX20 estudis
- New York City, NY19 estudis
- Jacksonville, FL19 estudis
- Washington, DC19 estudis
- Austin, TX18 estudis
Altres estudis a Pharr
De ClinicalTrials.gov, dades recuperades el 5 d’oct. 2026. Cada estudi estableix els seus propis criteris d'elegibilitat; l'equip de l'estudi decideix qui hi pot participar.